These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 15218849)

  • 1. A world without an HIV vaccine (or, sunrise with sea monsters). 11th conference on retroviruses and opportunistic infections. February 8-11, 2004, San Francisco.
    Mascolini M
    IAPAC Mon; 2004 Apr; 10(4):114-32. PubMed ID: 15218849
    [No Abstract]   [Full Text] [Related]  

  • 2. Rethinking STIs, revamping salvage, revisiting toxicity (or, the clouds of chronicity). 11th conference on retroviruses and opportunistic infections. February 8-11, 2004, San Francisco.
    Mascolini M
    IAPAC Mon; 2004 May; 10(5):154-76. PubMed ID: 15366102
    [No Abstract]   [Full Text] [Related]  

  • 3. Treating HCV infection in HIV/HCV-coinfected patients.
    Boyle B
    IAPAC Mon; 2004 Jan; 10(1):34-9. PubMed ID: 15108673
    [No Abstract]   [Full Text] [Related]  

  • 4. HIV & hepatitis C: treatment.
    WORLD; 2002 May; (133):4-5. PubMed ID: 12064298
    [No Abstract]   [Full Text] [Related]  

  • 5. 11th Conference on Retroviruses and Opportunistic Infections, San Francisco, 8-11 February 2004: where are the breakthroughs?
    Mallon PW
    J HIV Ther; 2004 Feb; 9(1):19-22. PubMed ID: 15587480
    [No Abstract]   [Full Text] [Related]  

  • 6. Delaying HCV treatment in HIV-positive patients.
    Carter M
    IAPAC Mon; 2005 May; 11(5):147. PubMed ID: 16201045
    [No Abstract]   [Full Text] [Related]  

  • 7. Long-term control of HIV replication with dolutegravir and pegylated interferon alpha-2a in an HIV-infected patient with sixtuple-class resistance.
    Montes ML; Schapiro J; Pérez-Valero I; García-Bujalance S; Arribas JR
    AIDS; 2014 Mar; 28(6):932-4. PubMed ID: 24614067
    [No Abstract]   [Full Text] [Related]  

  • 8. Pegylated interferon-alpha2a and ribavirin in HIV-hepatitis C coinfected patients.
    Expert Rev Anti Infect Ther; 2004 Jun; 2(3):341-2. PubMed ID: 15490503
    [No Abstract]   [Full Text] [Related]  

  • 9. [HIV and hepatitis C coinfection].
    Stoehr A; Brinkmann K; Sabranski M
    MMW Fortschr Med; 2008 Apr; 150 Spec No 1():54-5, 57. PubMed ID: 19024919
    [No Abstract]   [Full Text] [Related]  

  • 10. Sustained viral response after only 6 weeks of peginterferon and ribavirin treatment for acute hepatitis C in a HIV-1-infected patient.
    van den Berk GE; Arends JE
    AIDS; 2011 Jul; 25(12):1553-4. PubMed ID: 21747237
    [No Abstract]   [Full Text] [Related]  

  • 11. OPERA: use of pegylated interferon plus ribavirin for treating HCV-HIV coinfection in interferon-naive patients.
    Carosi G; Bruno R; Cariti G; Nasta P; Gulminetti R; Galli M; Angarano G; Verucchi G; Pontali E; Capetti A; Raise E; Ravasio V; Maida I; Iannacone C; Caputo A; Puoti M
    Antivir Ther; 2014; 19(8):735-45. PubMed ID: 24583976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of concomitant antiretroviral therapy on the rate of sustained virological response to pegylated interferon plus ribavirin in hepatitis C virus/HIV-coinfected patients.
    Pineda JA; Mira JA; Gil Ide L; Valera-Bestard B; Rivero A; Merino D; Girón-González JA; Ríos-Villegas MJ; González-Serrano M; Collado A; García-García JA; Carrillo-Gómez R; López-Cortés LF; Gómez-Mateos J
    J Antimicrob Chemother; 2007 Dec; 60(6):1347-54. PubMed ID: 17938129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early antiviral treatment of hepatitis C virus recurrence after liver transplantation in HIV-infected patients.
    Castells L; Esteban JI; Bilbao I; Vargas V; Allende H; Ribera E; Piron M; Sauleda S; Len O; Pahissa A; Esteban R; Guardia J; Margarit C
    Antivir Ther; 2006; 11(8):1061-70. PubMed ID: 17302376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A report from the Conference on Retroviruses and Opportunistic Infections (CROI) 2015 (February 23-26--Seattle, Washington, USA).
    Rabasseda X
    Drugs Today (Barc); 2015 Mar; 51(3):209-16. PubMed ID: 25876564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Progress in the treatment of hepatitis B and C co-infection in HIV patients].
    Mauss S
    MMW Fortschr Med; 2004 Apr; 146 Spec No 1():27-9. PubMed ID: 15373041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [HIV/HCV double infection: combination is a clear therapy option].
    Reich B
    Dtsch Med Wochenschr; 2004 Jul; 129(28-29):1590. PubMed ID: 15274242
    [No Abstract]   [Full Text] [Related]  

  • 17. Anti-HIV agents. Hepatitis C treatment and possible interactions with anti-HIV drugs.
    TreatmentUpdate; 2004; 16(3):2-4. PubMed ID: 17216833
    [No Abstract]   [Full Text] [Related]  

  • 18. Can drugs catch up with HIV? 12th Conference on Retroviruses and Opportunistic Infections. February 22-25, 2005, Boston.
    Mascolini M
    IAPAC Mon; 2005 Mar; 11(3):68-85. PubMed ID: 16110535
    [No Abstract]   [Full Text] [Related]  

  • 19. [Chronic hepatitis C and HIV. Current therapeutic options].
    Mauss S
    MMW Fortschr Med; 2001 Apr; 143 Suppl 1():46-9. PubMed ID: 11373779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meeting notes from ICAAC. Choosing the right HCV-coinfected patients to treat.
    Sax PE
    AIDS Clin Care; 2005 Jan; 17(1):7-8. PubMed ID: 15717375
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.